| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454753A1 Peptides having antiangiogenic activity |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2454147A1 Inhibitor of dna methylation |
| 02/13/2003 | CA2453939A1 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 02/13/2003 | CA2453661A1 (-)-olivil as antioxidant |
| 02/13/2003 | CA2453522A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | CA2453372A1 Methylation resistant vectors |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283209A1 Novel benzothiophene derivatives |
| 02/12/2003 | EP1283208A1 Novel benzofuran derivatives |
| 02/12/2003 | EP1283059A2 Therapeutic conjugates of toxins and drugs |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283053A1 Inhibitors of HER3 activity |
| 02/12/2003 | EP1283052A1 Pharmaceutical composition containing caspase-8 and /or caspase-9 useful for overcoming glucocorticoid- and cancer therapy-induced apoptosis of tumours |
| 02/12/2003 | EP1283049A1 Depletion of the lysine-pool to suppress malignant proliferation processes |
| 02/12/2003 | EP1283044A2 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 02/12/2003 | EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 02/12/2003 | EP1282638A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 02/12/2003 | EP1282631A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 02/12/2003 | EP1282621A1 Novel vitronectin receptor antagonists |
| 02/12/2003 | EP1282618A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
| 02/12/2003 | EP1282617A1 Hydantoin derivatives with affinity for somatostatin receptors |
| 02/12/2003 | EP1282615A1 Chroman derivatives as estrogenic compounds |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282613A1 A pharmaceutical composition containing the extract of saururus chinensis baill useful as and anticancer agent and a process for the preparation thereof |
| 02/12/2003 | EP1282609A2 Piperazinedione compounds |
| 02/12/2003 | EP1282604A1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 02/12/2003 | EP1282442A1 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 02/12/2003 | EP1282441A2 Treating t-cell mediated diseases by modulating dr6 activity |
| 02/12/2003 | EP1282440A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumor agents |
| 02/12/2003 | EP1282435A2 Interleukin-1 inhibitors in the treatment of diseases |
| 02/12/2003 | EP1282433A1 Transgenically produced decorin |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282411A1 Method of treating cancer |
| 02/12/2003 | EP1282403A1 Non-invasive gene targeting to the brain |
| 02/12/2003 | EP1282400A2 Pharmaceutical form of administration for peptides, methods for its production and use |
| 02/12/2003 | EP1282395A1 Use of ellagic acid as anti-pollution cosmetic agent |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1135169B1 Use of a pharmaceutical composition comprising an anti-cancer agent and at least a peptide |
| 02/12/2003 | EP0969877B1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 02/12/2003 | EP0947514B1 Novel phenanethridinium derivatives |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0841953B1 Method and apparatus for interstitial radiation of the prostate gland |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 02/12/2003 | EP0637246B1 Use of modified c-reactive protein for the preparation of a medicament for the treatment of cancer |
| 02/12/2003 | CN1396930A Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 02/12/2003 | CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396917A Chromatographic separation method of paclitaxel and cephalomannin |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396912A 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 02/12/2003 | CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396906A Calcilytic compounds |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396828A Pharmaceutical composition comprising Pemetrexed together with monothioglycerol L-cystein or thioglycolic acid |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396822A Liposomes containing entrapped compound in supersaturated solution |
| 02/12/2003 | CN1396181A Monoclonal antibody and its preparing process and usage |
| 02/12/2003 | CN1396177A Cyclopeptide compound phakellistatin 12 with anticancer activity |
| 02/12/2003 | CN1396172A Process for extracting compound cordycepin and its Chinese medicine |
| 02/12/2003 | CN1395960A Antineoplastic Chinese medicine |
| 02/12/2003 | CN1395944A Anticancer syrup and its preparing process |
| 02/12/2003 | CN1395939A Compound of solanesol and its preparing process |
| 02/12/2003 | CN1395922A Theopolyphenol composition for injection and its preparing process |
| 02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
| 02/12/2003 | CN1101391C Farnesyl transferase inhibiting 2-quinolone derivatives |
| 02/12/2003 | CN1101386C Trisubsted phenyl derivitives |
| 02/12/2003 | CN1101380C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101209C Medicine for treaitng digestive tract diseases |
| 02/12/2003 | CN1101204C Anti-cancer medicine and its producing method |
| 02/12/2003 | CN1101183C Sustained release and implantation type mitomycin medicine and method for preparing same |
| 02/12/2003 | CN1101182C Sustained release and implantation type antineoplasma medicine and method for preparing same |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/11/2003 | US6518426 Pyrimidine derivatives and methods of making and using these derivatives |